Silver Nitrate
In clinical developmentAlso known as Avoca, Nitrate d'argent, Nitrato de plata, Silver Nitrate Ophthalmic+4 more
Avoca, Nitrate d'argent, Nitrato de plata, Silver Nitrate Ophthalmic, Silver mononitrate, Silver nitrate (in water), Styptstix, silver(1+) nitrate.
Recent clinical, regulatory, research and industry developments relating to this drug.
Treatment of Tracheostomy Granulomas
Medical Management of Caries in the Primary Dentition Using Silver Nitrate: A Pilot Study
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes1
Journals, researchers & institutions
- Scientific reports1
- Abo-Elmagd RA1
- Bawazir SS1
- Hamouda RA1
- Hussein MH1
- Genetic Engineering & Research Institute1
- Mansoura University1
- University of Jeddah1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across the same disease area as Silver Nitrate in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials